【ChiCTR2200056204】ONLINE MINDFULNESS THERAPY AS A SMOKING CESSATION AID IN MALAYSIA: A RANDOMIZED CONTROL TRIAL
ChiCTR2200056204
尚未开始
/
/
/
2022-02-01
/
/
Non-communicable diseases
ONLINE MINDFULNESS THERAPY AS A SMOKING CESSATION AID IN MALAYSIA: A RANDOMIZED CONTROL TRIAL
ONLINE MINDFULNESS THERAPY AS A SMOKING CESSATION AID IN MALAYSIA: A RANDOMIZED CONTROL TRIAL
71800
General Objective To determine whether counselling or mindfulness therapy is a better intervention as a quit smoking aid among smokers. Specific Objectives 1. To compare the difference of the scores on Fagerstrom Test for Nicotine Dependence before and after intervention in the two intervention groups using counselling and mindfulness therapy. 2. To compare the difference of the scores on QSU-Brief before and after intervention in the two intervention groups using counselling and mindfulness therapy. 3. To compare the difference of the scores on DASS before and after intervention in the two intervention groups using counselling and mindfulness therapy. 4. To compare the difference of the scores on the mindfulness, attention, and awareness scale (MAAS) before and after intervention in the two intervention groups using counselling and mindfulness therapy. 5. To compare the difference of the scores on AAQ-2 before and after intervention in the two intervention groups using counselling and mindfulness therapy. 6. The compare difference and linear relationship of the number of average cigarettes smoked per day in the two intervention groups using counselling and mindfulness therapy.
随机抽样
Ⅰ期
All the eligible participants who were included into the study after the screening process will be randomized to either mindfulness therapy group or counselling group. The randomization process will completely be done by using computer generated randomization Excel software to excluded bias.
The intervention group will be labelled Group A for mindfulness therapy and Group B for counselling therapy, hence the participate only will be told which group they are assigned to without informing what kind of therapy they are subjected to undergo.
University Malaysia Sabah, Malaysia
/
79
/
2022-01-01
2023-10-01
/
1. Adult aged 18 to 60 years; 2. Smokers who are moderately dependent or highly dependent according to the Fagerstrom test; 3. Able to understand Malay and English moderately; 4. Have excess to the internet connection; 5. Currently residing in Malaysia.;
请登录查看1. Currently undergoing any other smoking cessation program which is conducted under private or government healthcare center (Quit smoking clinics); 2. On any kind of nicotine replacement therapy; 3. Currently using any kind of psychoactive medications; 4. Has a serious or unstable medical/mental condition.;
请登录查看University Malaysia Sabah, Malaysia
88400
University Malaysia Sabah, Malaysia的其他临床试验
马来西亚沙巴大学的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

